Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC plus steroids versus steroids alone for severe GVHD after allogeneic HSCT
2011-003237-33Phase 3Active
- Sponsor
- HOVON
- Start
- Aug 2013
- Modality
- Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of Provacel in Acute Graft-Versus-Host Disease (aGvHD), sponsored by HOVON. Started Aug 2013; status: active.
02
Drugs
Provacel
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on 2011-003237-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003237-33.